Health ❯ Cancer Treatment

Immunotherapy

CAR-T Therapy FDA Regulations Surgery CAR T Cell Therapy Chronic Inflammation Clinical Trials DDR Inhibitors Botensilimab Regulatory T-cells mRNA Technology IL-6 Inhibitors Immune Checkpoint Blockade Targeted Therapies Melanoma Chemotherapy Vaccine Design Cellular Therapy Tumor Shrinkage Therapeutic Interventions Patient Care T Regulatory Cells mRNA Vaccines Cold Tumors Androgen Signaling Side Effects Tumor Microenvironment Cancer Vaccines

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

The miss triggered target cuts alongside a securities investigation into prior comments.

Testosterone Loss Linked to Faster Glioblastoma Growth in Men

ImmunityBio Securities Fight Intensifies After FDA Rebuke Over Anktiva Claims

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

Brain Reward Training Linked to Higher Antibody Response After Hepatitis B Vaccine

OxLDL-Targeted CAR Tregs Cut Mouse Plaque 70% in Penn Study, Prompting Cartio Therapeutics

UW Engineers Program Proteins to Make Logic‑Gated Decisions for Targeted Drug Delivery

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Teddi Mellencamp Takes Immunotherapy Break After Scans Show Tumor Shrinkage

UCSF and Stanford Secure $100 Million Weill Matching Gift to Launch $200 Million West Coast Cancer Hub